LBA52 EMPOWER-Lung 1: Phase III first-line (1L) cemiplimab monotherapy vs platinum-doublet chemotherapy (chemo) in advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) ≥50%

Ahmet Sezer, Saadettin Kılıçkap, Mahmut Gümüş et al. · Annals of Oncology · 2020

Cited by 28 works. doi:10.1016/j.annonc.2020.08.2285 Open-access PDF

Authors